AC Immune believes it has hit on a breakthrough in vaccine technology with its Alzheimer’s candidate ACI-35. The rest of the world will have to wait to evaluate the claim, as the company and partner...
A third setback for the $5 billion Galapagos-Gilead deal will now see the partners turn their attention to another fibrosis candidate and a Toledo program that targets salt-inducible kinases. Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG) shed nearly $1.3...
House Democrats are starting what is certain to be a sustained effort to reduce U.S. drug prices by targeting a cap on Medicaid drug rebates that manufacturers must pay when price increases exceed inflation....
...“A coalition of legislators that value the contribution our industry makes to the nation is essential.”... ...“A coalition of legislators that value the contribution our industry makes to the nation is essential...
AC Immune believes it has hit on a breakthrough in vaccine technology with its Alzheimer’s candidate ACI-35. The rest of the world will have to wait to evaluate the claim, as the company and partner...
A third setback for the $5 billion Galapagos-Gilead deal will now see the partners turn their attention to another fibrosis candidate and a Toledo program that targets salt-inducible kinases. Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG) shed nearly $1.3...
House Democrats are starting what is certain to be a sustained effort to reduce U.S. drug prices by targeting a cap on Medicaid drug rebates that manufacturers must pay when price increases exceed inflation....
...“A coalition of legislators that value the contribution our industry makes to the nation is essential.”... ...“A coalition of legislators that value the contribution our industry makes to the nation is essential...
